How a layered approach—tapping new avenues from earned media—can go a long way in boosting the brand engagement interplay ...

Expanded approval of Wegovy was based on results from the Phase III ESSENCE trial (NCT04822181), which demonstrated ...

An examination of proactive preparedness and readiness review for future enrollment in the agency’s QMM program—now in the ...

What is MFN in pharma? President Trump’s executive order on drug pricing states that the United States should be treated as a ...

As global director of healthcare and sciences at Google Cloud, Shweta Maniar is working with organizations to find ways to ...

Pfizer's inclacumab fails Phase III study for sickle cell disease, disappointing the community while the company remains ...

The report details the administration’s potential plans for a variety of issues that will directly impact pharma.

Oikos Fusion offers a nutrient-dense dairy drink designed to support muscle mass and digestive health during weight loss ...

Eli Lilly is increasing Mounjaro's UK price by 170% to match European market levels, with the highest dose now costing £330.

Strategies for biopharma in integrating agentic AI—to achieve incremental gains in efficiency, while delivering meaningful ...

The milestone payment is partially funded through Sarepta’s Arrowhead stock sale as both companies push forward with ...

Superluminal partners with Eli Lilly to develop AI-driven small molecule therapies targeting GPCRs for obesity and ...